Neuroscience Technologies, a biomedical company with expertise in human pain neurophysiology that helps the pharmaceutical and biotechnology industries in assessing their new analgesic compounds with the use of objective biomarkers of spontaneous pain. Founded in 2005, Neuroscience Technologies opened a subsidiary in London in 2011, where it offers clinical human studies.
NT is embedded in the Science Park of Barcelona (PCB). The aim of the Park is to bring together public and private research environments, facilitating transfer of knowledge and innovation between the University and research environment and the business world. Created by the University of Barcelona in 1997, the PCB was the first Science Park in Spain and today we are an international benchmark for the promotion of innovation with more than 2,000 professionals.
The Park is currently home to three research institutes and about 70 companies and other organisations, offering furnished and non-furnished laboratories, as well as offices on a rental basis and a range of associated services. The PCB also organises activities promoting scientific culture and encouraging new scientific vocations in which nearly 4,500 people participate every year.